Portfolio company
Proveca
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops and licenses age-appropriate medicines to treat chronic conditions, including heart failure and severe drooling, in children and adolescents.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ProCorde AG
This cardiovascular-focused company develops therapies for thrombosis and vascular dysfunction to treat patients suffering from coronary artery disease and other cardiovascular pathologies.
Serca Pharmaceuticals
This company develops cardioprotective drugs to treat patients suffering from myocardial infarction and heart failure by modulating the SERCA2 calcium pump.
ViiV Healthcare
This company develops and provides pharmaceutical medicines for the treatment and prevention of HIV for patients and healthcare professionals.
Green Park Pharma
The company develops stable liquid formulations of existing medicines for patients who have difficulty swallowing traditional tablets and capsules.
Shorla
This pharmaceutical company develops and manufactures innovative oncology drugs for patients with rare, paediatric and orphan cancers where existing treatments are inadequate.
Aspire Pharma
This company licenses and develops niche generic and specialty pharmaceutical products for healthcare professionals, patients and the NHS.
ReViral
This company develops antiviral therapeutics for respiratory syncytial virus to treat pediatric, immunocompromised and elderly patients.
Cardurion Pharmaceuticals
This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.
